Healthcare logistics specialist Marken will open a dedicated pharmaceuticals depot in Moscow totarget the expanding Russian market and take its global depot network to seven locations.
The Russia depot will be located within an existing GxP-compliant storage facility in Moscow,offering a secure and dedicated space near the airport. The facility will be operated by dedicatedstaff trained on Marken’s global procedures and managed by the state of the art global inventorysystem, Solo, which provides clients with 24/7 access and monitoring of their global supplies anddistribution status.
Gerit Offenhauser, Marken’s Senior Vice President, Clinical Trials Distribution, said: “Thisco-location in Moscow offers clear market opportunities for our clients who have indicated a needfor clinical trial operations in Russia and Eastern Europe. We look forward to meeting the growingneeds for depot services in that part of the world.”
The announcement follows an exhaustive search for a high-quality fully-operational depotthat provides proximity to international airports and shipping lanes. Marken has a significanttransportation capability in Russia, a country which remains an important clinical trialcentre. This new depot capability allows the company to expand its portfolio of services inthe region.
The new Moscow site is seamlessly integrated into the existing and growing Marken depotnetwork already serving the pharmaceutical industry, joining the network of depots in China,Singapore, Argentina, Mexico, Germany and the United States. Further locations are planned inBrazil, Chile and Columbia.
Marken said its network of pharmaceutical depot facilities and supporting IT systems aredesigned to provide the most flexible and efficient storage and distribution of materials for theclinical trials community. They are designed for all clinical materials, and are particularlysuited for temperature-controlled, time sensitive products which are emerging in mostpharmaceutical company pipelines.
